|
注册号: Registration number: |
ChiCTR2600127013 |
|
最近更新日期: Date of Last Refreshed on: |
2026-06-23 09:09:01 |
|
注册时间: Date of Registration: |
2026-06-23 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
沁神清润草本牙膏缓解牙周炎的有效性与安全性的随机、双盲、安慰剂平行对照临床试验 |
|
Public title: |
A Randomized, Double-blind, Placebo-controlled Trial on the Efficacy and Safety of Qinshen Qingrun Herbal Toothpaste in Alleviating Periodontitis |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
沁神清润草本牙膏缓解牙周炎的有效性与安全性的随机、双盲、安慰剂平行对照临床试验 |
|
Scientific title: |
A Randomized, Double-blind, Placebo-controlled Trial on the Efficacy and Safety of Qinshen Qingrun Herbal Toothpaste in Alleviating Periodontitis |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刁艳君 |
研究负责人: |
刘显 |
|
Applicant: |
Yanjun Diao |
Study leader: |
Xian Liu |
|
申请注册联系人电话: Applicant telephone: |
+86 187 2819 8050 |
研究负责人电话:
Study leader's |
+86 28 8550 1452 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
18109066740@163.com |
研究负责人电子邮件: Study leader's E-mail: |
18109066740@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
成都市武侯区人民南路三段14号 |
研究负责人通讯地址: |
成都市武侯区人民南路三段14号 |
|
Applicant address: |
No. 14, Section 3, Renmin South Road, Wuhou District, Chengdu, China |
Study leader's address: |
No. 14, Section 3, Renmin South Road, Wuhou District, Chengdu, China |
|
申请注册联系人邮政编码: Applicant postcode: |
610041 |
研究负责人邮政编码: Study leader's postcode: |
610041 |
|
申请人所在单位: |
四川大学华西口腔医院 |
||
|
Applicant's institution: |
West China Hospital of Stomatology, Sichuan University |
||
|
研究负责人所在单位: |
四川大学华西口腔医院 |
||
|
Affiliation of the Leader: |
West China Hospital of Stomatology, Sichuan University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
WCHSIRB-D-2026-278 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
四川大学华西口腔医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Institutional Review Board, West China Hospital of Stomatology, Sichuan University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-05-28 00:00:00 | ||
|
伦理委员会联系人: |
李灏来 |
||
|
Contact Name of the ethic committee: |
Haolai Li |
||
|
伦理委员会联系地址: |
成都市武侯区人民南路三段14号 |
||
|
Contact Address of the ethic committee: |
No. 14, Section 3, Renmin South Road, Wuhou District, Chengdu, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 28 8550 1479 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
四川大学华西口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
West China Hospital of Stomatology, Sichuan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
成都市武侯区人民南路三段14号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 14, Section 3, Renmin South Road, Wuhou District, Chengdu, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
重庆神奕科技有限公司 |
||||||||||||||||||||||
|
Source(s) of funding: |
Chongqing Shenyu Technology Co., Ltd. |
||||||||||||||||||||||
|
研究疾病: |
牙周炎 |
||||||||||||||||||||||
|
Target disease: |
Periodontitis |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
评价沁神清润草本牙膏缓解牙周炎的有效性和安全性。 |
||||||||||||||||||||||
|
Objectives of Study: |
Assessment of the Efficacy and Safety of Qinshen Qingrun Herbal Toothpaste in Alleviating Periodontitis. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1)对本次试验所用产品任何成分有自我报告过敏史者; 2)孕妇及哺乳期妇女; 3)近3月内进行过洁治、刮治等牙周治疗者; 4)近14天内使用过激素、抗生素等药物者; 5)肝功能损害或肾功能不全者; 6)存在甲状腺机能异常、血液疾病、急性病毒性口炎、创伤性溃疡、神经系统疾病、精神系统疾病等; 7)同时参加了其他临床试验且未达到临床终点,或近3个月内参加过其他临床试验; 8)无法完成或配合试验流程者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Those who have a history of self-reported allergies to any of the ingredients used in this trial; 2. Pregnant and lactating women; 3. Those who have undergone periodontal treatment such as cleaning and scaling in the past 3 months; 4. Those who have used hormones, antibiotics and other drugs in the past 14 days; 5. Patients with liver impairment or renal insufficiency; 6. Abnormal thyroid function, blood diseases, acute viral stomatitis, traumatic ulcers, nervous system diseases, psychiatric diseases, etc.; 7. Participated in other clinical trials at the same time and did not meet the clinical endpoints, or participated in other clinical trials in the past 3 months; 8. Those who are unable to complete or cooperate with the test process. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-06-30 00:00:00至 To 2027-06-29 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-06-30 00:00:00 至 To 2027-06-29 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机数字表 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Random number table |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
受试者、检查者双盲 |
|
Blinding: |
Subjects and examiners were double-blinded |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
知情同意书及随访文书记录统一专柜管理,电子数据专门电脑记录管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Informed consent forms and follow-up documentation shall be stored in a designated locked cabinet, while electronic data shall be managed through a dedicated computer system. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |